{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T03:44:30Z","timestamp":1791776670323,"version":"4.3.4"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Sanofi-Aventis Deutschland GmbH, Germany"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Respiratory syncytial virus (RSV) is a major cause of acute lower respiratory infection and hospitalizations among infants, young children, and the elderly. This systematic literature review aimed to summarize the epidemiological and economic burden estimates of RSV infection at any age in Germany.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a systematic literature search to identify full-text articles published from 2003 to 2023 and reporting data on the epidemiological or economic burden of RSV in Germany. Based on pre-specified eligibility criteria, data on incidence, rates of hospital and intensive care unit (ICU) admission, clinical manifestation, underlying conditions, seasonality, health care resource use and costs were extracted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After screening 315 full-text articles, we included 42 articles in the review. The characteristics of the included studies were heterogenous regarding study population, setting, age groups and RSV-related outcome measures.<\/jats:p>\n                    <jats:p>\n                      The most frequently reported epidemiological outcome measures were RSV detection rate (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200933), followed by clinical manifestation (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200919), seasonality (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200918), and underlying conditions of RSV infection (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200913). RSV detection rates were reported across heterogenous study populations, ranging from 5.2 to 55.4% in pediatric inpatient cases and from 2.9 to 14% in adult inpatient cases. All articles that reported RSV detection rates across several age groups demonstrated the highest burden in infants and young children. Few articles reported RSV-related outcome measures distinctively for the outpatient setting.\n                    <\/jats:p>\n                    <jats:p>Health care resource use, such as hospital length of stay, ICU admission rate and treatment of patients with RSV infection were described in 23 articles, of which only one study quantified associated costs from 1999 to 2003 for children\u2009\u2264\u20093 years. In-hospital ICU admission rates varied between 3.6 and 45%, depending on population characteristics as age and underlying conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This systematic review revealed that RSV imposes substantial disease burden in infants, young children, and the elderly in Germany, whereby infants are particularly affected. To date, there has been limited exploration of the impact of RSV infection on healthy children or the elderly in Germany. Given their notably high reported burden in studies, the medical and economic RSV burden in these groups should move more into focus.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-024-09758-3","type":"journal-article","created":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T14:02:47Z","timestamp":1724162567000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Burden of respiratory syncytial virus (RSV) infection in Germany: a systematic review"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5190-5617","authenticated-orcid":false,"given":"Anahita","family":"Poshtiban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3032-6354","authenticated-orcid":false,"given":"Moritz","family":"Wick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1320-8145","authenticated-orcid":false,"given":"Mathieu","family":"Bangert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0261-3655","authenticated-orcid":false,"given":"Oliver","family":"Damm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,20]]},"reference":[{"issue":"10098","key":"9758_CR1","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/S0140-6736(17)30938-8","volume":"390","author":"T Shi","year":"2017","unstructured":"Shi T, McAllister DA, O\u2019Brien KL, Simoes EAF, Madhi SA, Gessner BD, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. 2017;390(10098):946\u201358. https:\/\/doi.org\/10.1016\/S0140-6736(17)30938-8.","journal-title":"Lancet"},{"issue":"6","key":"9758_CR2","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/irv.12885","volume":"15","author":"L Staadegaard","year":"2021","unstructured":"Staadegaard L, Caini S, Wangchuk S, Thapa B, de Almeida WAF, de Carvalho FC, et al. Defining the seasonality of respiratory syncytial virus around the world: National and subnational surveillance data from 12 countries. Influenza Other Respir Viruses. 2021;15(6):732\u201341. https:\/\/doi.org\/10.1111\/irv.12885.","journal-title":"Influenza Other Respir Viruses"},{"issue":"10340","key":"9758_CR3","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","volume":"399","author":"Y Li","year":"2022","unstructured":"Li Y, Wang X, Blau DM, Caballero MT, Feikin DR, Gill CJ, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet. 2022;399(10340):2047\u201364. https:\/\/doi.org\/10.1016\/S0140-6736(22)00478-0.","journal-title":"Lancet"},{"issue":"9","key":"9758_CR4","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1093\/infdis\/jiy056","volume":"217","author":"P Obando-Pacheco","year":"2018","unstructured":"Obando-Pacheco P, Justicia-Grande AJ, Rivero-Calle I, Rodriguez-Tenreiro C, Sly P, Ramilo O, et al. Respiratory Syncytial Virus Seasonality: A Global Overview. J Infect Dis. 2018;217(9):1356\u201364. https:\/\/doi.org\/10.1093\/infdis\/jiy056.","journal-title":"J Infect Dis"},{"issue":"1","key":"9758_CR5","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1186\/s12879-021-06399-8","volume":"21","author":"C Demont","year":"2021","unstructured":"Demont C, Petrica N, Bardoulat I, Duret S, Watier L, Chosidow A, et al. Economic and disease burden of RSV-associated hospitalizations in young children in France, from 2010 through 2018. BMC Infect Dis. 2021;21(1):730. https:\/\/doi.org\/10.1186\/s12879-021-06399-8.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"9758_CR6","doi-asserted-by":"publisher","first-page":"e13145","DOI":"10.1111\/irv.13145","volume":"17","author":"Y Duan","year":"2023","unstructured":"Duan Y, Jiang M, Huang Q, Jia M, Yang W, Feng L. Incidence, hospitalization, and mortality in children aged 5 years and younger with respiratory syncytial virus-related diseases: a systematic review and meta-analysis. Influenza Other Respir Viruses. 2023;17(5):e13145. https:\/\/doi.org\/10.1111\/irv.13145.","journal-title":"Influenza Other Respir Viruses"},{"key":"9758_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad188","author":"M Del Riccio","year":"2023","unstructured":"Del Riccio M, Spreeuwenberg P, Osei-Yeboah R, Johannesen CK, Vazquez Fernandez L, Teirlinck AC, et al. Defining the Burden of Disease of RSV in the European Union: estimates of RSV-associated hospitalisations in children under 5 years of age. A systematic review and modelling study. J Infect Dis. 2023. https:\/\/doi.org\/10.1093\/infdis\/jiad188.","journal-title":"J Infect Dis"},{"issue":"3","key":"9758_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s40121-016-0123-0","volume":"5","author":"L Bont","year":"2016","unstructured":"Bont L, Checchia PA, Fauroux B, Figueras-Aloy J, Manzoni P, Paes B, et al. Defining the epidemiology and burden of severe respiratory syncytial virus infection among infants and children in Western Countries. Infect Dis Ther. 2016;5(3):271\u201398. https:\/\/doi.org\/10.1007\/s40121-016-0123-0.","journal-title":"Infect Dis Ther"},{"issue":"6","key":"9758_CR9","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1001\/archpedi.1986.02140200053026","volume":"140","author":"WP Glezen","year":"1986","unstructured":"Glezen WP, Taber LH, Frank AL, Kasel JA. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child. 1986;140(6):543\u20136. https:\/\/doi.org\/10.1001\/archpedi.1986.02140200053026.","journal-title":"Am J Dis Child"},{"issue":"1","key":"9758_CR10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1056\/NEJMra1413456","volume":"374","author":"HC Meissner","year":"2016","unstructured":"Meissner HC. Viral bronchiolitis in children. N Engl J Med. 2016;374(1):62\u201372. https:\/\/doi.org\/10.1056\/NEJMra1413456.","journal-title":"N Engl J Med"},{"issue":"Suppl 7","key":"9758_CR11","doi-asserted-by":"publisher","first-page":"S577","DOI":"10.1093\/infdis\/jiz059","volume":"222","author":"T Shi","year":"2020","unstructured":"Shi T, Denouel A, Tietjen AK, Campbell I, Moran E, Li X, et al. Global Disease Burden estimates of respiratory Syncytial Virus-Associated Acute respiratory infection in older adults in 2015: a systematic review and Meta-analysis. J Infect Dis. 2020;222(Suppl 7):S577\u201383. https:\/\/doi.org\/10.1093\/infdis\/jiz059.","journal-title":"J Infect Dis"},{"issue":"S 02","key":"9758_CR12","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1055\/s-0040-1714345","volume":"37","author":"E Baraldi","year":"2020","unstructured":"Baraldi E, Bonadies L, Manzoni P. Evidence on the link between respiratory syncytial virus infection in Early Life and Chronic Obstructive Lung diseases. Am J Perinatol. 2020;37(S 02):S26\u201330. https:\/\/doi.org\/10.1055\/s-0040-1714345.","journal-title":"Am J Perinatol"},{"issue":"2","key":"9758_CR13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1164\/rccm.200406-730OC","volume":"171","author":"N Sigurs","year":"2005","unstructured":"Sigurs N, Gustafsson PM, Bjarnason R, Lundberg F, Schmidt S, Sigurbergsson F, et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med. 2005;171(2):137\u201341. https:\/\/doi.org\/10.1164\/rccm.200406-730OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"9758_CR14","unstructured":"CDC. RSV in Older Adults and Adults with Chronic Medical Conditions. https:\/\/www.cdc.gov\/rsv\/high-risk\/older-adults.html Accessed 26 October 2023."},{"issue":"2","key":"9758_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/cid\/ciy991","volume":"69","author":"B Ackerson","year":"2019","unstructured":"Ackerson B, Tseng HF, Sy LS, Solano Z, Slezak J, Luo Y, et al. Severe morbidity and mortality Associated with respiratory Syncytial Virus Versus Influenza infection in hospitalized older adults. Clin Infect Dis. 2019;69(2):197\u2013203. https:\/\/doi.org\/10.1093\/cid\/ciy991.","journal-title":"Clin Infect Dis"},{"key":"9758_CR16","doi-asserted-by":"publisher","unstructured":"Krilov LR, Roberts NJ. Jr. Respiratory syncytial virus (RSV) update. Viruses. 2022;14(10). https:\/\/doi.org\/10.3390\/v14102110.","DOI":"10.3390\/v14102110"},{"issue":"6","key":"9758_CR17","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/irv.12729","volume":"14","author":"W Cai","year":"2020","unstructured":"Cai W, Buda S, Schuler E, Hirve S, Zhang W, Haas W. Risk factors for hospitalized respiratory syncytial virus disease and its severe outcomes. Influenza Other Respir Viruses. 2020b;14(6):658\u201370. https:\/\/doi.org\/10.1111\/irv.12729.","journal-title":"Influenza Other Respir Viruses"},{"issue":"7","key":"9758_CR18","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1002\/ppul.25435","volume":"56","author":"E Shmueli","year":"2021","unstructured":"Shmueli E, Goldberg O, Mei-Zahav M, Stafler P, Bar-On O, Levine H, et al. Risk factors for respiratory syncytial virus bronchiolitis hospitalizations in children with chronic diseases. Pediatr Pulmonol. 2021;56(7):2204\u201311. https:\/\/doi.org\/10.1002\/ppul.25435.","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"9758_CR19","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1093\/infdis\/jiac137","volume":"226","author":"K Hartmann","year":"2022","unstructured":"Hartmann K, Liese JG, Kemmling D, Prifert C, Weissbrich B, Thilakarathne P, et al. Clinical burden of respiratory Syncytial Virus in Hospitalized Children aged =5 years (INSPIRE study)<\/at. J Infect Dis. 2022;226(3):386\u201395. https:\/\/doi.org\/10.1093\/infdis\/jiac137.","journal-title":"J Infect Dis"},{"issue":"5","key":"9758_CR20","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1093\/jpids\/piz087","volume":"9","author":"CS Arriola","year":"2020","unstructured":"Arriola CS, Kim L, Langley G, Anderson EJ, Openo K, Martin AM, et al. Estimated Burden of Community-Onset Respiratory Syncytial Virus-Associated hospitalizations among children aged\u2009<\u20092 years in the United States, 2014-15. J Pediatr Infect Dis Soc. 2020;9(5):587\u201395. https:\/\/doi.org\/10.1093\/jpids\/piz087.","journal-title":"J Pediatr Infect Dis Soc"},{"key":"9758_CR21","doi-asserted-by":"publisher","unstructured":"Rha B, Curns AT, Lively JY, Campbell AP, Englund JA, Boom JA, et al. Respiratory Syncytial Virus-Associated hospitalizations among Young children: 2015\u20132016. Pediatrics. 2020;146(1). https:\/\/doi.org\/10.1542\/peds.2019-3611.","DOI":"10.1542\/peds.2019-3611"},{"issue":"1","key":"9758_CR22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/s0034-5687(01)00261-4","volume":"128","author":"KC Meyer","year":"2001","unstructured":"Meyer KC. The role of immunity in susceptibility to respiratory infection in the aging lung. Respir Physiol. 2001;128(1):23\u201331. https:\/\/doi.org\/10.1016\/s0034-5687(01)00261-4.","journal-title":"Respir Physiol"},{"issue":"17","key":"9758_CR23","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1056\/NEJMoa043951","volume":"352","author":"AR Falsey","year":"2005","unstructured":"Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med. 2005;352(17):1749\u201359. https:\/\/doi.org\/10.1056\/NEJMoa043951.","journal-title":"N Engl J Med"},{"key":"9758_CR24","doi-asserted-by":"publisher","first-page":"105666","DOI":"10.1016\/j.earlhumdev.2022.105666","volume":"174","author":"A Messina","year":"2022","unstructured":"Messina A, Germano C, Avellis V, Tavella E, Dodaro V, Massaro A, et al. New strategies for the prevention of respiratory syncytial virus (RSV). Early Hum Dev. 2022;174:105666. https:\/\/doi.org\/10.1016\/j.earlhumdev.2022.105666.","journal-title":"Early Hum Dev"},{"issue":"1","key":"9758_CR25","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1016\/S1473-3099(22)00291-2","volume":"23","author":"NI Mazur","year":"2023","unstructured":"Mazur NI, Terstappen J, Baral R, Bardaji A, Beutels P, Buchholz UJ, et al. Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape. Lancet Infect Dis. 2023;23(1):e2\u201321. https:\/\/doi.org\/10.1016\/S1473-3099(22)00291-2.","journal-title":"Lancet Infect Dis"},{"key":"9758_CR26","unstructured":"European Medicines Agency. Synagis - palivizumab. Annex I - Summary of product characteristics. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/synagis-epar-product-information_en.pdf. Accessed 22 July 2024."},{"key":"9758_CR27","unstructured":"Gemeinsamer Bundesausschuss. Bekanntmachung eines Beschlusses des Gemeinsamen Bundesausschusses \u00fcber eine \u00c4nderung der Arzneimittel-Richtlinie in Anlage 4: Therapiehinweis zu Palivizumab [BAnz. Nr. 181 (S. 4 260) vom 27.11.2008]. https:\/\/www.g-ba.de\/downloads\/39-261-694\/2008-06-19-AMR4-Palivizumab_BAnz.pdf. Accessed 22 July 2024."},{"key":"9758_CR28","doi-asserted-by":"publisher","unstructured":"Buda S, Preu\u00df U. Robert Koch-Institut. Bericht zur Epidemiologie der Influenza in Deutschland, Saison 2018\/19, Berlin. 2019. https:\/\/doi.org\/10.25646\/6232","DOI":"10.25646\/6232"},{"key":"9758_CR29","unstructured":"Robert Koch-Institut. FAQ-Liste zu RSV-Infektionen. https:\/\/www.rki.de\/SharedDocs\/FAQ\/RSV\/FAQ_Liste_RSV.html. Accessed 26 October 2023."},{"key":"9758_CR30","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535. https:\/\/doi.org\/10.1136\/bmj.b2535.","journal-title":"BMJ"},{"issue":"3","key":"9758_CR31","doi-asserted-by":"publisher","first-page":"e1003583","DOI":"10.1371\/journal.pmed.1003583","volume":"18","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. PLoS Med. 2021;18(3):e1003583. https:\/\/doi.org\/10.1371\/journal.pmed.1003583.","journal-title":"PLoS Med"},{"issue":"5","key":"9758_CR32","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1023\/a:1024213400297","volume":"18","author":"JA Weigl","year":"2003","unstructured":"Weigl JA, Puppe W, Schmitt HJ. Can respiratory syncytial virus etiology be diagnosed clinically? A hospital-based case-control study in children under two years of age. Eur J Epidemiol. 2003;18(5):431\u20139. https:\/\/doi.org\/10.1023\/a:1024213400297.","journal-title":"Eur J Epidemiol"},{"key":"9758_CR33","doi-asserted-by":"publisher","first-page":"105209","DOI":"10.1016\/j.meegid.2022.105209","volume":"98","author":"J Tabatabai","year":"2022","unstructured":"Tabatabai J, Ihling CM, Rehbein RM, Schnee SV, Hoos J, Pfeil J, et al. Molecular epidemiology of respiratory syncytial virus in hospitalised children in Heidelberg, Southern Germany, 2014\u20132017. Infect Genet Evol. 2022;98:105209. https:\/\/doi.org\/10.1016\/j.meegid.2022.105209.","journal-title":"Infect Genet Evol"},{"issue":"3","key":"9758_CR34","doi-asserted-by":"publisher","first-page":"ofad110","DOI":"10.1093\/ofid\/ofad110","volume":"10","author":"J Tabatabai","year":"2023","unstructured":"Tabatabai J, Ihling CM, Manuel B, Rehbein RM, Schnee SV, Hoos J, et al. Viral etiology and clinical characteristics of Acute Respiratory Tract infections in Hospitalized Children in Southern Germany (2014\u20132018). Open Forum Infect Dis. 2023;10(3):ofad110. https:\/\/doi.org\/10.1093\/ofid\/ofad110.","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"9758_CR35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1055\/s-2004-817688","volume":"216","author":"JA Weigl","year":"2004","unstructured":"Weigl JA, Puppe W, Schmitt HJ. Variables explaining the duration of hospitalization in children under two years of age admitted with acute airway infections: does respiratory syncytial virus have a direct impact? Klin Padiatr. 2004;216(1):7\u201315. https:\/\/doi.org\/10.1055\/s-2004-817688.","journal-title":"Klin Padiatr"},{"issue":"5","key":"9758_CR36","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/irv.12666","volume":"13","author":"M An der Heiden","year":"2019","unstructured":"An der Heiden M, Buchholz U, Buda S. Estimation of influenza- and respiratory syncytial virus-attributable medically attended acute respiratory infections in Germany, 2010\/11-2017\/18. Influenza Other Respir Viruses. 2019;13(5):517\u201321. https:\/\/doi.org\/10.1111\/irv.12666.","journal-title":"Influenza Other Respir Viruses"},{"issue":"4","key":"9758_CR37","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00705-013-1876-3","volume":"159","author":"S Bierbaum","year":"2014","unstructured":"Bierbaum S, Forster J, Berner R, Rucker G, Rohde G, Neumann-Haefelin D, et al. Detection of respiratory viruses using a multiplex real-time PCR assay in Germany, 2009\/10. Arch Virol. 2014;159(4):669\u201376. https:\/\/doi.org\/10.1007\/s00705-013-1876-3.","journal-title":"Arch Virol"},{"issue":"6","key":"9758_CR38","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/irv.12665","volume":"14","author":"W Cai","year":"2020","unstructured":"Cai W, Tolksdorf K, Hirve S, Schuler E, Zhang W, Haas W, et al. Evaluation of using ICD-10 code data for respiratory syncytial virus surveillance. Influenza Other Respir Viruses. 2020a;14(6):630\u20137. https:\/\/doi.org\/10.1111\/irv.12665.","journal-title":"Influenza Other Respir Viruses"},{"issue":"5","key":"9758_CR39","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/irv.12996","volume":"16","author":"W Cai","year":"2022","unstructured":"Cai W, Durrwald R, Biere B, Schweiger B, Haas W, Wolff T, et al. Determination of respiratory syncytial virus epidemic seasons by using 95% confidence interval of positivity rates, 2011\u20132021, Germany. Influenza Other Respir Viruses. 2022;16(5):854\u20137. https:\/\/doi.org\/10.1111\/irv.12996.","journal-title":"Influenza Other Respir Viruses"},{"issue":"10","key":"9758_CR40","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00431-005-1705-0","volume":"164","author":"B Ehlken","year":"2005","unstructured":"Ehlken B, Ihorst G, Lippert B, Rohwedder A, Petersen G, Schumacher M, et al. Economic impact of community-acquired and nosocomial lower respiratory tract infections in young children in Germany. Eur J Pediatr. 2005;164(10):607\u201315. https:\/\/doi.org\/10.1007\/s00431-005-1705-0.","journal-title":"Eur J Pediatr"},{"issue":"10 Suppl","key":"9758_CR41","doi-asserted-by":"publisher","first-page":"S215","DOI":"10.1097\/01.inf.0000092190.43140.f7","volume":"22","author":"J Forster","year":"2003","unstructured":"Forster J. Influenza in children: the German perspective. Pediatr Infect Dis J. 2003;22(10 Suppl):S215-7. https:\/\/doi.org\/10.1097\/01.inf.0000092190.43140.f7.","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"9758_CR42","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00431-004-1523-9","volume":"163","author":"J Forster","year":"2004","unstructured":"Forster J, Ihorst G, Rieger CH, Stephan V, Frank HD, Gurth H, et al. Prospective population-based study of viral lower respiratory tract infections in children under 3 years of age (the PRI.DE study). Eur J Pediatr. 2004;163(12):709\u201316. https:\/\/doi.org\/10.1007\/s00431-004-1523-9.","journal-title":"Eur J Pediatr"},{"issue":"2","key":"9758_CR43","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s15010-013-0545-5","volume":"42","author":"B Gr\u00f6ndahl","year":"2014","unstructured":"Gr\u00f6ndahl B, Ankermann T, von Bismarck P, Rockahr S, Kowalzik F, Gehring S, et al. The 2009 pandemic influenza A(H1N1) coincides with changes in the epidemiology of other viral pathogens causing acute respiratory tract infections in children. Infection. 2014;42(2):303\u20138. https:\/\/doi.org\/10.1007\/s15010-013-0545-5.","journal-title":"Infection"},{"key":"9758_CR44","doi-asserted-by":"publisher","first-page":"105530","DOI":"10.1016\/j.jcv.2023.105530","volume":"166","author":"A Kiefer","year":"2023","unstructured":"Kiefer A, Pemmerl S, Kabesch M, Ambrosch A. Comparative analysis of RSV-related hospitalisations in children and adults over a 7 year-period before, during and after the COVID-19 pandemic. J Clin Virol. 2023;166:105530. https:\/\/doi.org\/10.1016\/j.jcv.2023.105530.","journal-title":"J Clin Virol"},{"issue":"4","key":"9758_CR45","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s00431-002-1105-7","volume":"162","author":"JG Liese","year":"2003","unstructured":"Liese JG, Grill E, Fischer B, Roeckl-Wiedmann I, Carr D, Belohradsky BH, et al. Incidence and risk factors of respiratory syncytial virus-related hospitalizations in premature infants in Germany. Eur J Pediatr. 2003;162(4):230\u20136. https:\/\/doi.org\/10.1007\/s00431-002-1105-7.","journal-title":"Eur J Pediatr"},{"issue":"6","key":"9758_CR46","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1128\/JCM.02286-08","volume":"47","author":"J Reiche","year":"2009","unstructured":"Reiche J, Schweiger B. Genetic variability of group a human respiratory syncytial virus strains circulating in Germany from 1998 to 2007. J Clin Microbiol. 2009;47(6):1800\u201310. https:\/\/doi.org\/10.1128\/JCM.02286-08.","journal-title":"J Clin Microbiol"},{"issue":"12","key":"9758_CR47","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s00431-007-0426-y","volume":"166","author":"A Simon","year":"2007","unstructured":"Simon A, Ammann RA, Wilkesmann A, Eis-Hubinger AM, Schildgen O, Weimann E, et al. Respiratory syncytial virus infection in 406 hospitalized premature infants: results from a prospective German multicentre database. Eur J Pediatr. 2007;166(12):1273\u201383. https:\/\/doi.org\/10.1007\/s00431-007-0426-y.","journal-title":"Eur J Pediatr"},{"issue":"3\u20134","key":"9758_CR48","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ijheh.2007.07.020","volume":"211","author":"A Simon","year":"2008","unstructured":"Simon A, Muller A, Khurana K, Engelhart S, Exner M, Schildgen O, et al. Nosocomial infection: a risk factor for a complicated course in children with respiratory syncytial virus infection\u2013results from a prospective multicenter German surveillance study. Int J Hyg Environ Health. 2008;211(3\u20134):241\u201350. https:\/\/doi.org\/10.1016\/j.ijheh.2007.07.020.","journal-title":"Int J Hyg Environ Health"},{"issue":"5","key":"9758_CR49","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1055\/s-0030-1270515","volume":"223","author":"A Simon","year":"2011","unstructured":"Simon A, Nowak H, Sterz R. Use of palivizumab in Germany: data from 2002\u20132007. Klin Padiatr. 2011;223(5):292\u20138. https:\/\/doi.org\/10.1055\/s-0030-1270515.","journal-title":"Klin Padiatr"},{"issue":"5","key":"9758_CR50","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1055\/a-0595-7771","volume":"230","author":"A Simon","year":"2018","unstructured":"Simon A, Gehrmann S, Wagenpfeil G, Wagenpfeil S. Use of Palivizumab in Germany - Report from the German Synagis Registry 2009\u20132016. Klin Padiatr. 2018a;230(5):263\u20139. https:\/\/doi.org\/10.1055\/a-0595-7771.","journal-title":"Klin Padiatr"},{"issue":"10","key":"9758_CR51","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1097\/INF.0000000000002133","volume":"37","author":"A Simon","year":"2018","unstructured":"Simon A, Gehrmann S, Wagenpfeil G, Wagenpfeil S. Risk factors and main indications for Palivizumab Prophylaxis in a second season Population: results from the German Synagis Registry 2009\u20132016. Pediatr Infect Dis J. 2018b;37(10):987\u201391. https:\/\/doi.org\/10.1097\/INF.0000000000002133.","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"9758_CR52","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s00431-018-3142-x","volume":"177","author":"A Simon","year":"2018","unstructured":"Simon A, Gehrmann S, Wagenpfeil G, Wagenpfeil S. Palivizumab use in infants with Down syndrome-report from the German Synagis Registry 2009\u20132016. Eur J Pediatr. 2018c;177(6):903\u201311. https:\/\/doi.org\/10.1007\/s00431-018-3142-x.","journal-title":"Eur J Pediatr"},{"issue":"1","key":"9758_CR53","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1186\/s12879-019-4266-y","volume":"19","author":"A Streng","year":"2019","unstructured":"Streng A, Goettler D, Haerlein M, Lehmann L, Ulrich K, Prifert C, et al. Spread and clinical severity of respiratory syncytial virus a genotype ON1 in Germany, 2011\u20132017. BMC Infect Dis. 2019;19(1):613. https:\/\/doi.org\/10.1186\/s12879-019-4266-y.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"9758_CR54","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1007\/s15010-022-01889-6","volume":"50","author":"T Tenenbaum","year":"2022","unstructured":"Tenenbaum T, Doenhardt M, Diffloth N, Berner R, Armann JP. High burden of RSV hospitalizations in Germany 2021\u20132022. Infection. 2022;50(6):1587\u201390. https:\/\/doi.org\/10.1007\/s15010-022-01889-6.","journal-title":"Infection"},{"key":"9758_CR55","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-2334-5-20","volume":"5","author":"E Terletskaia-Ladwig","year":"2005","unstructured":"Terletskaia-Ladwig E, Enders G, Schalasta G, Enders M. Defining the timing of respiratory syncytial virus (RSV) outbreaks: an epidemiological study. BMC Infect Dis. 2005;5:20. https:\/\/doi.org\/10.1186\/1471-2334-5-20.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"9758_CR56","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1055\/s-2004-822699","volume":"217","author":"JA Weigl","year":"2005","unstructured":"Weigl JA, Puppe W, Belke O, Neususs J, Bagci F, Schmitt HJ. Population-based incidence of severe pneumonia in children in Kiel. Ger Klin Padiatr. 2005;217(4):211\u20139. https:\/\/doi.org\/10.1055\/s-2004-822699.","journal-title":"Ger Klin Padiatr"},{"issue":"9","key":"9758_CR57","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s00431-007-0496-x","volume":"166","author":"JA Weigl","year":"2007","unstructured":"Weigl JA, Puppe W, Meyer CU, Berner R, Forster J, Schmitt HJ, et al. Ten years\u2019 experience with year-round active surveillance of up to 19 respiratory pathogens in children. Eur J Pediatr. 2007;166(9):957\u201366. https:\/\/doi.org\/10.1007\/s00431-007-0496-x.","journal-title":"Eur J Pediatr"},{"issue":"4","key":"9758_CR58","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s10096-017-3158-6","volume":"37","author":"R Weinberger","year":"2018","unstructured":"Weinberger R, Riffelmann M, Kennerknecht N, Hulsse C, Littmann M, O\u2019Brien J, et al. Long-lasting cough in an adult German population: incidence, symptoms, and related pathogens. Eur J Clin Microbiol Infect Dis. 2018;37(4):665\u201372. https:\/\/doi.org\/10.1007\/s10096-017-3158-6.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"9758_CR59","doi-asserted-by":"publisher","unstructured":"Wetzke M, Schutz K, Kopp MV, Seidenberg J, Vogelberg C, Ankermann T, et al. Pathogen Spectra in hospitalised and nonhospitalised children with community-acquired pneumonia. ERJ Open Res. 2023;9(2). https:\/\/doi.org\/10.1183\/23120541.00286-2022.","DOI":"10.1183\/23120541.00286-2022"},{"issue":"6","key":"9758_CR60","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/INF.0b013e31805d01e3","volume":"26","author":"A Wilkesmann","year":"2007","unstructured":"Wilkesmann A, Ammann RA, Schildgen O, Eis-Hubinger AM, Muller A, Seidenberg J, et al. Hospitalized children with respiratory syncytial virus infection and neuromuscular impairment face an increased risk of a complicated course. Pediatr Infect Dis J. 2007;26(6):485\u201391. https:\/\/doi.org\/10.1097\/INF.0b013e31805d01e3.","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"9758_CR61","doi-asserted-by":"publisher","first-page":"e3809","DOI":"10.1016\/j.cmi.2018.05.023","volume":"25","author":"M Alchikh","year":"2019","unstructured":"Alchikh M, Conrad T, Hoppe C, Ma X, Broberg E, Penttinen P, et al. Are we missing respiratory viral infections in infants and children? Comparison of a hospital-based quality management system with standard of care. Clin Microbiol Infect. 2019;25(3):e3809\u201316. https:\/\/doi.org\/10.1016\/j.cmi.2018.05.023.","journal-title":"Clin Microbiol Infect"},{"key":"9758_CR62","doi-asserted-by":"publisher","first-page":"105399","DOI":"10.1016\/j.jcv.2023.105399","volume":"161","author":"A Ambrosch","year":"2023","unstructured":"Ambrosch A, Luber D, Klawonn F, Kabesch M. Focusing on severe infections with the respiratory syncytial virus (RSV) in adults: risk factors, symptomatology and clinical course compared to influenza A \/ B and the original SARS-CoV-2 strain. J Clin Virol. 2023;161:105399. https:\/\/doi.org\/10.1016\/j.jcv.2023.105399.","journal-title":"J Clin Virol"},{"key":"9758_CR63","doi-asserted-by":"publisher","unstructured":"H\u00f6nemann M, Thiem S, Bergs S, Berthold T, Propach C, Siekmeyer M, et al. In-Depth analysis of the re-emergence of respiratory Syncytial Virus at a Tertiary Care Hospital in Germany in the summer of 2021 after the alleviation of non-pharmaceutical interventions due to the SARS-CoV-2 pandemic. Viruses. 2023;15(4). https:\/\/doi.org\/10.3390\/v15040877.","DOI":"10.3390\/v15040877"},{"issue":"2","key":"9758_CR64","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s15010-022-01756-4","volume":"50","author":"N Maison","year":"2022","unstructured":"Maison N, Peck A, Illi S, Meyer-Buehn M, von Mutius E, Hubner J, et al. The rising of old foes: impact of lockdown periods on non-SARS-CoV-2 viral respiratory and gastrointestinal infections. Infection. 2022;50(2):519\u201324. https:\/\/doi.org\/10.1007\/s15010-022-01756-4.","journal-title":"Infection"},{"issue":"1\u20132","key":"9758_CR65","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00430-003-0215-9","volume":"194","author":"R Mentel","year":"2005","unstructured":"Mentel R, Ilgert U, Wegner U, Zimmerman K, Bruns R, Gurtler L. Molecular and clinical characteristics of respiratory syncytial virus infections in hospitalized children. Med Microbiol Immunol. 2005;194(1\u20132):67\u201371. https:\/\/doi.org\/10.1007\/s00430-003-0215-9.","journal-title":"Med Microbiol Immunol"},{"issue":"12","key":"9758_CR66","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1093\/infdis\/jiac052","volume":"226","author":"M Meyer","year":"2022","unstructured":"Meyer M, Ruebsteck E, Eifinger F, Klein F, Oberthuer A, van Koningsbruggen-Rietschel S, et al. Morbidity of respiratory syncytial virus (RSV) infections: RSV compared with severe Acute Respiratory Syndrome Coronavirus 2 infections in children aged 0\u20134 years in Cologne, Germany. J Infect Dis. 2022;226(12):2050\u20133. https:\/\/doi.org\/10.1093\/infdis\/jiac052.","journal-title":"J Infect Dis"},{"issue":"2","key":"9758_CR67","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s15010-018-1194-5","volume":"47","author":"D Schreiner","year":"2019","unstructured":"Schreiner D, Groendahl B, Puppe W, Off HNT, Poplawska K, Knuf M, et al. High antibiotic prescription rates in hospitalized children with human metapneumovirus infection in comparison to RSV infection emphasize the value of point-of-care diagnostics. Infection. 2019;47(2):201\u20137. https:\/\/doi.org\/10.1007\/s15010-018-1194-5.","journal-title":"Infection"},{"issue":"10","key":"9758_CR68","doi-asserted-by":"publisher","first-page":"e109191","DOI":"10.1371\/journal.pone.0109191","volume":"9","author":"J Tabatabai","year":"2014","unstructured":"Tabatabai J, Prifert C, Pfeil J, Grulich-Henn J, Schnitzler P. Novel respiratory syncytial virus (RSV) genotype ON1 predominates in Germany during winter season 2012-13. PLoS ONE. 2014;9(10):e109191. https:\/\/doi.org\/10.1371\/journal.pone.0109191.","journal-title":"PLoS ONE"},{"issue":"3","key":"9758_CR69","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s15010-018-1262-x","volume":"47","author":"S Topoulos","year":"2019","unstructured":"Topoulos S, Giesa C, Gatermann S, Fussen R, Lemmen S, Ewig S. Analysis of acute respiratory infections due to influenza virus A, B and RSV during an influenza epidemic 2018. Infection. 2019;47(3):425\u201333. https:\/\/doi.org\/10.1007\/s15010-018-1262-x.","journal-title":"Infection"},{"issue":"1","key":"9758_CR70","doi-asserted-by":"publisher","first-page":"6","DOI":"10.7883\/yoken.JJID.2014.424","volume":"69","author":"M Vogel","year":"2016","unstructured":"Vogel M, Grund S, Pandey S, Mayatepek E, Schroten H, Tenenbaum T, et al. What we have learned from the Influenza A pH1N1 2009\/10 pandemic: high clinical impact of human metapneumovirus and respiratory Syncytial Virus in Hospitalized Pediatric patients. Jpn J Infect Dis. 2016;69(1):6\u201311. https:\/\/doi.org\/10.7883\/yoken.JJID.2014.424.","journal-title":"Jpn J Infect Dis"},{"issue":"5","key":"9758_CR71","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1055\/s-2007-990301","volume":"220","author":"S Wasem","year":"2008","unstructured":"Wasem S, Weichert S, Walther S, Weigl JA, Puppe W, Ihorst G, et al. Lower respiratory tract disease in children: constant pathogens - constant management?! Klin Padiatr. 2008;220(5):291\u20135. https:\/\/doi.org\/10.1055\/s-2007-990301.","journal-title":"Klin Padiatr"},{"issue":"Suppl 7","key":"9758_CR72","doi-asserted-by":"publisher","first-page":"S599","DOI":"10.1093\/infdis\/jiaa360","volume":"222","author":"RM Reeves","year":"2020","unstructured":"Reeves RM, van Wijhe M, Tong S, Lehtonen T, Stona L, Teirlinck AC, et al. Respiratory Syncytial Virus-Associated Hospital admissions in children younger than 5 years in 7 European Countries using routinely collected datasets. J Infect Dis. 2020;222(Suppl 7):S599\u2013605. https:\/\/doi.org\/10.1093\/infdis\/jiaa360.","journal-title":"J Infect Dis"},{"key":"9758_CR73","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad189","author":"R Osei-Yeboah","year":"2023","unstructured":"Osei-Yeboah R, Spreeuwenberg P, Del Riccio M, Fischer TK, Egeskov-Cavling AM, Boas H, et al. Estimation of the number of RSV-associated hospitalisations in adults in the European Union. J Infect Dis. 2023. https:\/\/doi.org\/10.1093\/infdis\/jiad189.","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"9758_CR74","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1093\/infdis\/jiac150","volume":"226","author":"CK Johannesen","year":"2022","unstructured":"Johannesen CK, van Wijhe M, Tong S, Fernandez LV, Heikkinen T, van Boven M, et al. Age-specific estimates of respiratory Syncytial Virus-Associated hospitalizations in 6 European countries: a Time Series Analysis. J Infect Dis. 2022;226(Suppl 1):S29\u201337. https:\/\/doi.org\/10.1093\/infdis\/jiac150.","journal-title":"J Infect Dis"},{"issue":"4","key":"9758_CR75","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s40121-016-0130-1","volume":"5","author":"J Figueras-Aloy","year":"2016","unstructured":"Figueras-Aloy J, Manzoni P, Paes B, Simoes EA, Bont L, Checchia PA, et al. Defining the risk and Associated Morbidity and Mortality of severe respiratory syncytial virus infection among Preterm infants without chronic lung disease or congenital heart disease. Infect Dis Ther. 2016;5(4):417\u201352. https:\/\/doi.org\/10.1007\/s40121-016-0130-1.","journal-title":"Infect Dis Ther"},{"issue":"5","key":"9758_CR76","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.jcrc.2011.12.001","volume":"27","author":"KL Hon","year":"2012","unstructured":"Hon KL, Leung TF, Cheng WY, Ko NM, Tang WK, Wong WW, et al. Respiratory syncytial virus morbidity, premorbid factors, seasonality, and implications for prophylaxis. J Crit Care. 2012;27(5):464\u20138. https:\/\/doi.org\/10.1016\/j.jcrc.2011.12.001.","journal-title":"J Crit Care"},{"issue":"3","key":"9758_CR77","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s40121-017-0160-3","volume":"6","author":"P Manzoni","year":"2017","unstructured":"Manzoni P, Figueras-Aloy J, Simoes EAF, Checchia PA, Fauroux B, Bont L, et al. Defining the incidence and Associated Morbidity and Mortality of severe respiratory syncytial virus infection among children with chronic diseases. Infect Dis Ther. 2017;6(3):383\u2013411. https:\/\/doi.org\/10.1007\/s40121-017-0160-3.","journal-title":"Infect Dis Ther"},{"issue":"2","key":"9758_CR78","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/infdis\/jis333","volume":"206","author":"J Papenburg","year":"2012","unstructured":"Papenburg J, Hamelin ME, Ouhoummane N, Carbonneau J, Ouakki M, Raymond F, et al. Comparison of risk factors for human metapneumovirus and respiratory syncytial virus disease severity in young children. J Infect Dis. 2012;206(2):178\u201389. https:\/\/doi.org\/10.1093\/infdis\/jis333.","journal-title":"J Infect Dis"},{"key":"9758_CR79","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-023-02122-8","author":"P Niekler","year":"2023","unstructured":"Niekler P, Goettler D, Liese JG, Streng A. Hospitalizations due to respiratory syncytial virus (RSV) infections in Germany: a nationwide clinical and direct cost data analysis (2010\u20132019). Infection. 2023. https:\/\/doi.org\/10.1007\/s15010-023-02122-8.","journal-title":"Infection"},{"issue":"4","key":"9758_CR80","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.prrv.2015.05.005","volume":"16","author":"PM Brown","year":"2015","unstructured":"Brown PM, Schneeberger DL, Piedimonte G. Biomarkers of respiratory syncytial virus (RSV) infection: specific neutrophil and cytokine levels provide increased accuracy in predicting disease severity. Paediatr Respir Rev. 2015;16(4):232\u201340. https:\/\/doi.org\/10.1016\/j.prrv.2015.05.005.","journal-title":"Paediatr Respir Rev"},{"issue":"1","key":"9758_CR81","first-page":"2","volume":"10","author":"F Fusco","year":"2022","unstructured":"Fusco F, Hocking L, Stockwell S, Bonsu M, Marjanovic S, et al. The burden of respiratory syncytial virus: understanding impacts on the NHS, society and economy. Rand Health Q. 2022;10(1):2 PMID: 36484078.","journal-title":"Rand Health Q"},{"issue":"40","key":"9758_CR82","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.15585\/mmwr.mm7240a2","volume":"72","author":"D Surie","year":"2023","unstructured":"Surie D, Yuengling KA, DeCuir J, Zhu Y, Gaglani M, Ginde AA, et al. Disease Severity of Respiratory Syncytial Virus compared with COVID-19 and Influenza among hospitalized adults aged >\/=60 years - IVY Network, 20 U.S. States, February 2022-May 2023. MMWR Morb Mortal Wkly Rep. 2023;72(40):1083\u20138. https:\/\/doi.org\/10.15585\/mmwr.mm7240a2.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"11","key":"9758_CR83","doi-asserted-by":"publisher","first-page":"e13211","DOI":"10.1111\/irv.13211","volume":"17","author":"M Wick","year":"2023","unstructured":"Wick M, Poshtiban A, Kramer R, Bangert M, Lange M, Wetzke M, et al. Inpatient burden of respiratory syncytial virus in children =2 years of age in Germany: a retrospective analysis of nationwide hospitalization data, 2019\u20132022<\/at. Influenza Other Respir Viruses. 2023;17(11):e13211. https:\/\/doi.org\/10.1111\/irv.13211.","journal-title":"Influenza Other Respir Viruses"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09758-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-09758-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09758-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T14:03:55Z","timestamp":1724162635000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-09758-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,20]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["9758"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-09758-3","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,20]]},"assertion":[{"value":"18 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable as this work did not gather patient or individual-level data, or involve any interventions, formal ethical approval was not sought, and informed consent was not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"A. P., M. W. and O. D. are employees of Sanofi-Aventis Deutschland GmbH, and M.B. of Sanofi Vaccines and all may hold shares and\/or stock options in the company.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"844"}}